Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor

This study has been completed.
Information provided by (Responsible Party):
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies Identifier:
First received: November 15, 2005
Last updated: May 6, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2006
  Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)